141 related articles for article (PubMed ID: 36933377)
1. Eliciting effective tumor immunity against ovarian cancer by cancer stem cell vaccination.
Xu H; Zhao F; Wu D; Zhang Y; Bao X; Shi F; Cai Y; Dou J
Biomed Pharmacother; 2023 May; 161():114547. PubMed ID: 36933377
[TBL] [Abstract][Full Text] [Related]
2. Ovarian Cancer Stem Cells with High ROR1 Expression Serve as a New Prophylactic Vaccine for Ovarian Cancer.
Wu D; Yu X; Wang J; Hui X; Zhang Y; Cai Y; Ren M; Guo M; Zhao F; Dou J
J Immunol Res; 2019; 2019():9394615. PubMed ID: 31008116
[TBL] [Abstract][Full Text] [Related]
3. Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine.
Wu D; Wang J; Cai Y; Ren M; Zhang Y; Shi F; Zhao F; He X; Pan M; Yan C; Dou J
J Ovarian Res; 2015 Oct; 8():68. PubMed ID: 26497895
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
5. Effective tumor immunity to melanoma mediated by B16F10 cancer stem cell vaccine.
Zhao F; Zhang R; Wang J; Wu D; Pan M; Li M; Guo M; Dou J
Int Immunopharmacol; 2017 Nov; 52():238-244. PubMed ID: 28950176
[TBL] [Abstract][Full Text] [Related]
6. Epithelial ovarian cancer stem-like cells expressing α-gal epitopes increase the immunogenicity of tumor associated antigens.
Yao X; Dong Z; Zhang Q; Wang Q; Lai D
BMC Cancer; 2015 Dec; 15():956. PubMed ID: 26673159
[TBL] [Abstract][Full Text] [Related]
7. Cancer Stem Cell Vaccination With PD-L1 and CTLA-4 Blockades Enhances the Eradication of Melanoma Stem Cells in a Mouse Tumor Model.
Zheng F; Dang J; Zhang H; Xu F; Ba D; Zhang B; Cheng F; Chang AE; Wicha MS; Li Q
J Immunother; 2018 Oct; 41(8):361-368. PubMed ID: 30063587
[TBL] [Abstract][Full Text] [Related]
8. MUC1 plays an essential role in tumor immunity of colorectal cancer stem cell vaccine.
Guo M; Luo B; Pan M; Li M; Zhao F; Dou J
Int Immunopharmacol; 2020 Aug; 85():106631. PubMed ID: 32470879
[TBL] [Abstract][Full Text] [Related]
9. The surface dominant antigen MUC1 is required for colorectal cancer stem cell vaccine to exert anti-tumor efficacy.
Guo M; You C; Dong W; Luo B; Wu Y; Chen Y; Li J; Pan M; Li M; Zhao F; Dou J
Biomed Pharmacother; 2020 Dec; 132():110804. PubMed ID: 33017767
[TBL] [Abstract][Full Text] [Related]
10. Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44/CD117 in human ovarian cancer SKOV3 cells.
Fan Y; Cheng H; Liu Y; Liu S; Lowe S; Li Y; Bentley R; King B; Tuason JPW; Zhou Q; Sun C; Zhang H
Front Pharmacol; 2022; 13():955984. PubMed ID: 36046821
[No Abstract] [Full Text] [Related]
11. Preventive cancer stem cell-based vaccination modulates tumor development in syngeneic colon adenocarcinoma murine model.
Eini L; Naseri M; Karimi-Busheri F; Bozorgmehr M; Ghods R; Madjd Z
J Cancer Res Clin Oncol; 2023 Jul; 149(7):4101-4116. PubMed ID: 36040667
[TBL] [Abstract][Full Text] [Related]
12. Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.
Xu Q; Liu G; Yuan X; Xu M; Wang H; Ji J; Konda B; Black KL; Yu JS
Stem Cells; 2009 Aug; 27(8):1734-40. PubMed ID: 19536809
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell vaccination confers significant antitumor immunity.
Ning N; Pan Q; Zheng F; Teitz-Tennenbaum S; Egenti M; Yet J; Li M; Ginestier C; Wicha MS; Moyer JS; Prince ME; Xu Y; Zhang XL; Huang S; Chang AE; Li Q
Cancer Res; 2012 Apr; 72(7):1853-64. PubMed ID: 22473314
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.
Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with embryonic stem cells generates effective antitumor immunity against ovarian cancer.
Zhang Z; Chen X; Chang X; Ye X; Li Y; Cui H
Int J Mol Med; 2013 Jan; 31(1):147-53. PubMed ID: 23174760
[TBL] [Abstract][Full Text] [Related]
16. Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity.
Huang J; Li M; Mei B; Li J; Zhu Y; Guo Q; Huang J; Zhang G
J Transl Med; 2022 Oct; 20(1):496. PubMed ID: 36316782
[TBL] [Abstract][Full Text] [Related]
17. A new strategy for enhancing antitumor immune response using dendritic cells loaded with chemo-resistant cancer stem-like cells in experimental mice model.
El-Ashmawy NE; El-Zamarany EA; Salem ML; Khedr EG; Ibrahim AO
Mol Immunol; 2019 Jul; 111():106-117. PubMed ID: 31051312
[TBL] [Abstract][Full Text] [Related]
18. Observation of ovarian cancer stem cell behavior and investigation of potential mechanisms of drug resistance in three-dimensional cell culture.
Chen J; Wang J; Zhang Y; Chen D; Yang C; Kai C; Wang X; Shi F; Dou J
J Biosci Bioeng; 2014 Aug; 118(2):214-22. PubMed ID: 24684961
[TBL] [Abstract][Full Text] [Related]
19. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.
Xu S; Yue Y; Zhang S; Zhou C; Cheng X; Xie X; Wang X; Lu W
J Exp Clin Cancer Res; 2018 Dec; 37(1):305. PubMed ID: 30518424
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting.
Hu Y; Lu L; Xia Y; Chen X; Chang AE; Hollingsworth RE; Hurt E; Owen J; Moyer JS; Prince ME; Dai F; Bao Y; Wang Y; Whitfield J; Xia JC; Huang S; Wicha MS; Li Q
Cancer Res; 2016 Aug; 76(16):4661-72. PubMed ID: 27325649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]